Investigation urgently needed into treatment of mentally ill immigration detainees at California facility, editorial states

NewsGuard 100/100 Score

"Although the number of mentally ill immigration detainees" at the La Mesa, Calif.-based private psychiatric hospital Alvarado Parkway Institute "at any one time seems to range from as few as two to only five or so, their situation needs to be addressed quickly," a San Diego Tribune editorial states (San Diego Tribune, 5/19).

Some disability rights lawyers and advocates for the mentally ill say that conditions at many of the private facilities, including API, violate state and federal laws governing treatment of mentally ill people. Ann Menasche, a lawyer with the legal advocacy group Disability Rights California, last month sent a letter to the U.S. Immigration and Customs Enforcement claiming that after visiting API and interviewing detainees, she found that the conditions are "excessive, unjustifiable and punitive" (Kaiser Health Disparities Report, 5/18).

According to the Tribune, "California's strict patients' rights laws specify that psychiatric patients can have daily visitors, use the telephone, exercise, socialize and be free from restraint unless the chief of the facility determines that a specific individual is a threat to himself or others," but, according to Menasche, patients at API are being denied those rights. The editorial adds that the conditions Menasche describes "may sound appalling, but it is unclear whether they are proper for the circumstances," and an "independent probe by the state Department of Public Health ... is needed to determine whether the detainees are being treated properly" (San Diego Tribune, 5/19).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients